Search research articles
Contact Us
Filters
Showing results (51-60 of 54) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 54 results.
The Plant Journal : for Cell and Molecular Biology
|
November 24, 2022
An NBS-LRR protein in the Rpp1 locus negates the dominance of Rpp1-mediated resistance against Phakopsora pachyrhizi in soybean
Wei Wei, Xing Wu, Alexandre Garcia, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik
|
August 1, 2018
Mapping of novel salt tolerance QTL in an Excalibur × Kukri doubled haploid wheat population
Muhammad A Asif, Rhiannon K Schilling, Joanne Tilbrook, et al.
BMC Genomics
|
April 1, 2025
Whole exome sequencing shows novel COL4A3 and COL4A4 variants as causes of Alport syndrome in Rio Grande do Norte, Brazil
Washington Candeia de Araújo, Raul Maia Falcão, Raquel Araujo Costa Uchoa, et al.
Epilepsia Open
|
October 29, 2024
BRIVA-ONE study: 12-month outcomes of brivaracetam monotherapy in clinical practice
Vicente Villanueva, Esther González Villar, Alejandro Fernandez-Cabrera, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 54) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 54 results.
The Plant Journal : for Cell and Molecular Biology
|
November 24, 2022
An NBS-LRR protein in the Rpp1 locus negates the dominance of Rpp1-mediated resistance against Phakopsora pachyrhizi in soybean
Wei Wei, Xing Wu, Alexandre Garcia, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik
|
August 1, 2018
Mapping of novel salt tolerance QTL in an Excalibur × Kukri doubled haploid wheat population
Muhammad A Asif, Rhiannon K Schilling, Joanne Tilbrook, et al.
BMC Genomics
|
April 1, 2025
Whole exome sequencing shows novel COL4A3 and COL4A4 variants as causes of Alport syndrome in Rio Grande do Norte, Brazil
Washington Candeia de Araújo, Raul Maia Falcão, Raquel Araujo Costa Uchoa, et al.
Epilepsia Open
|
October 29, 2024
BRIVA-ONE study: 12-month outcomes of brivaracetam monotherapy in clinical practice
Vicente Villanueva, Esther González Villar, Alejandro Fernandez-Cabrera, et al.
Page
of 6